Human AP Endonuclease 1: A potential marker for the prediction of environmental carcinogenesis risk

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Park, Jae Sung ^a,b   Kim, Hye Lim ^c   Kim, Yeo Jin ^c   Weon, Jong Il ^d   Sung, Mi Kyung ^e   Chung, Hai Won ^b   Seo, Young Rok ^c  

^a National Institute of Environmental Research   (South Korea)

^b Seoul National University   (South Korea)

^c Dongguk University   (South Korea)

^d Dongguk University   (South Korea)

^e Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GENES; HEAVY METALS; IONIZING RADIATION; PATHOLOGY; TRANSCRIPTION;

CARCINOGENIC RISK; ENVIRONMENTAL CHEMICALS; ENVIRONMENTAL FACTORS; ENVIRONMENTAL TOXICANTS; GENE-ENVIRONMENT INTERACTION; GENETIC VARIABILITY; NEURODEGENERATION; REDOX REGULATION;

NEURODEGENERATIVE DISEASES;

ARSENIC; CADMIUM; CARCINOGEN; CIGARETTE SMOKE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; ENVIRONMENTAL CHEMICAL; HEAVY METAL; LEAD; TRANSCRIPTION FACTOR; TUMOR MARKER; APEX1 PROTEIN, HUMAN;

AGE DISTRIBUTION; CANCER RISK; CARCINOGENESIS; DISEASE MARKER; DNA REPAIR; ENVIRONMENTAL DISEASE; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IONIZING RADIATION; NEUROPATHOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN FUNCTION; REVIEW; SMOKING; ULTRAVIOLET RADIATION; ANIMAL; ENVIRONMENT; GENETICS; METABOLISM; RISK FACTOR;

ANIMALS; CARCINOGENESIS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; ENVIRONMENT; GENE-ENVIRONMENT INTERACTION; HUMANS; RISK FACTORS;

EID: 84930808429     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/730301     Document Type: Review

References (188)

1. G. Tell, D. Fantini, and F. Quadrifoglio, " Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment," Cellular and Molecular Life Sciences, vol. 67, no. 21, pp. 3589-3608, 2010.
2. S. Xanthoudakis, G. G. Miao, and T. Curran, "The redox and DNA-repair activities of Ref-1 are encoded by nonoverlappi ng domains," Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 1, pp. 23-27, 1994.
3. M. Luo, S.Delaplane,A. Jiang et al., " Role of themultifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1, " Antioxidants and Redox Signaling, vol. 10, no. 11, pp. 1853-1867, 2008.
4. D. R. McNeill and D. M. Wilson III, " A dominant-negative formof themajor human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents," Molecular Cancer Research, vol. 5, no. 1, pp. 61-70, 2007.
5. A. R. Evans,M. Limp-Foster, andM.R.Kelley, " GoingAPEover ref-1," Mutation Research-DNA Repair, vol. 461, no. 2, pp. 83-108, 2000.
6. M. M. Georgia dis, M. Luo, R. K. Gaur, S. Delaplane, X. Li, and M. R. Kelley, " Evolution of the redox function in mammalian apurinic/apyrimidinic endonuclease," Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 643, no. 1 -2, pp. 54-63, 2008.
7. D. Fantini, C. Vascotto, D. Marasco et al., " Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions, " Nucleic Acids Research, vol. 38, no. 22, pp. 8239-8256, 2010.
8. J. Y. Park andY.R. Seo, "The protective role ofNrf2 incadmiuminduced DNA damage, " Molecular and Cellular Toxicology, vol. 7, no. 1, pp. 61-66, 2011.
9. H. L. Kim and Y. R. Seo, " Synergistic genotoxic effect between gene and environmental pollutant: oxidative DNA damage induced by thioredoxin reductase 1 silencing under nickel treatment, " Molecular and Cellular Toxicology, vol. 7, no. 3, pp. 251-257, 2011.
10. J. Y. Park, Y. J. Lee, P. Koedrith, and Y. R. Seo, " Protective role of thioredoxin reductase 1 in cadmium-induced DNA damage," Molecular and Cellular Toxicology, vol. 8, no. 3, pp. 289-295, 2012.
11. H. L. Kim and Y. R. Seo, " Molecular and genomic approach for understanding the gene-environment interaction between Nrf2 defciency and carcinogenic nickel-inducedDNA damage, " Oncology Reports, vol. 28, no. 6, pp. 1959-1967, 2012.
12. P. T. Beernink,B.W. SegelkeM. Z.Hadi,J. P. Erzberger,D. M. Wilson III,B. Rupp Two divalent metal ions in the active site of a new crystal form of human apurinic/apyrimidinic endonuclease, Ape1: implications for the catalytic mechanism, " Journal ofMolecular Biology 307, 4, 1023- 1034, 2001.
13. M. X. Li and D. M. Wilson, "Human apurinic/apyrimidinic endonuclease 1, " Antioxidants & Redox Signaling, vol. 20, no. 4, pp. 678-707, 2014.
14. G. Tell, F. Quadrifoglio, C. Tiribelli, and M. R. Kelley, " The many functions of APE1/Ref-1: not only a DNA repair enzyme," Antioxidants and Redox Signaling, vol. 11, no. 3, pp. 601-619, 2009.
15. D. M. Flaherty, M. M. Monick, and G. W. Hunninghake, "AP endonucleases and the many functions of Ref-1, " The American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 6, pp. 664-667, 2001.
16. T. Izumi, D. B. Brown, C. V. Naidu et al., " Two essential but distinct functions of the mammalian abasic endonuclease," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5739-5743, 2005.
17. D. R.Marenstein, D. M.Wilson III, and G.W. Teebor, " Human AP endonuclease (APE1) demonstrates endonucleolytic activity against AP sites in single-stranded DNA," DNA Repair, vol. 3, no. 5, pp. 527-533, 2004.
18. D. M. Wilson III and D. Barsky, " The major human abasic endonuclease: Formation, consequences and repair of abasic lesions in DNA," Mutation Research/DNA Repair, vol. 485, no. 4, pp. 283-307, 2001.
19. L. A. Loeb and B. D. Preston, "Mutagenesis by apurinic/apyrimidinic sites, " Annual Review of Genetics, vol. 20, pp. 201-230, 1986.
20. E. Seeberg, L. Eide, and M. Bjoras, "The base excision repair pathway, " Trends in Biochemical Sciences, vol. 20,no. 10, pp. 391-397, 1995.
21. T. A. Winters, W. D. Henner, P. S. Russell, A. McCullough, and T. J. Jorgensen, " Removal of 3-phosphoglycolate from DNA strand-break damage in an oligonucleotide substrate by recombinant human apurinic/apyrimidinic endonuclease 1, " Nucleic Acids Research, vol. 22, no. 10, pp. 1866-1873, 1994.
22. D. Suh, D. M. Wilson III, and L. F. Povirk, "3-Phosphodiesterase activity of human apurinic/apyrimidinic
23. endonuclease at DNA double-strand break ends," Nucleic Acids Research, vol. 25, no. 12, pp. 2495-2500, 1997.
24. G. Barzilay, C. D. Mol, C. N. Robson et al., " Identification of critical active-site residues in the multifunctional human DNA repair enzymeHAP1, " Nature Structural Biology, vol. 2, no. 7, pp. 561-568, 1995.
25. D. M.Wilson III, M. Takeshita, A. P. Grollman, and B. Demple, " Incision activity of human apurinic endonuclease (Ape) at abasic site analogs inDNA," Journal of Biological Chemistry, vol. 270, no. 27, pp. 16002-16007, 1995.
26. D. S. Chen, T. Herman, and B. Demple, " Two distinct human DNA diesterases that hydrolyze 3-blocking deoxyribose fragments from oxidized DNA," Nucleic Acids Research, vol. 19, no. 21, pp. 5907-5914, 1991.
27. B. Demple and L. Harrison, "Repair of oxidative damage to DNA: enzymology and biology, " Annual Reviewof Biochemistry, vol. 63, pp. 915-948, 1994.
28. L.Wiederhold, J. B. Leppard, P. Kedar et al., " AP endonucleaseindependent DNA base excision repair in human cells," Molecular Cell, vol. 15, no. 2, pp. 209-220, 2004.
29. T. Izumi, L. R. Wiederhold, G. Roy et al., " Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage," Toxicology, vol. 193, no. 1- 2, pp. 43-65, 2003. [29] D. M. Flaherty, M. M. Monick, A. B. Carter, M. W. Peterson, and G.W.Hunninghake, " Oxidant-mediated increases in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestos-treated macrophages, " Journal of Immunology, vol. 168, no. 11, pp. 5675-5681, 2002.
30. D. M. Flaherty, M. M. Monick, A. B. Carter, M. W. Peterson, and G.W.Hunninghake, " Oxidant-mediated increases in redox factor-1 nuclear protein and activator protein-1 DNA binding in asbestos-treated macrophages, " Journal of Immunology, vol. 168, no. 11, pp. 5675-5681, 2002
31. T. K. Hazra, Y. W. Kow, Z. Hatahet et al., " Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions, "The Journal of Biological Chemistry, vol. 277, no. 34, pp. 30417-30420, 2002.
32. G. Tell, G. Damante, D. Caldwell, and M. R. Kelley, "The intracellular loc alization of APE1/Ref-1: more than a passive phenomenon?" Antioxidants and Redox Signaling, vol. 7, no. 3- 4, pp. 367-384, 2005.
33. I. I. Dianova, V. A. Bohr, and G. L. Dianov, "Interactio n of human AP endonuclease 1 with flap endonuclease 1 and proliferating cell nuclear antigen involved in long-patch base excision repair," Biochemistry, vol. 40, no. 42, pp. 12639-12644, 2001.
34. K. Kim S. Biade, Y. Matsumoto Involvement of flap endonuclease 1 in base excision DNA repair The Journal of Biological Chemistry 273 ,15 ,8842-8848, 1998.
35. A. Klungland and T. Lindahl, " Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement forDNase IV(FEN1)," TheEMBO Journal, vol. 16, no. 11, pp. 3341-3348, 1997.
36. H. J. Jung, E.H. Kim, J.-Y.Mun et al., " Base excisionDNArepair defect in Gadd45a-deficient cells," Oncogene, vol. 26, no. 54, pp. 7517-7525, 2007.
37. H. L. Kim, S. U. Kim , and Y. R. Seo, " A novel role for Gadd45 in base excision repair: modulation of APE1 activity by the direct interaction of Gadd45 with PCNA," Biochemical and Biophysical Research Communications, vol. 434, no. 2, pp. 185-190, 2013.
38. H. J. Jung, H. L. Kim, Y. J. Kim, J. Weon, and Y. R. Seo, " A novel chemopreventive mechanism of selenomethionine: enhancement of APE1 enzyme activity via a Gadd45a, PCNA and APE1 protein complex that regulates p53-mediated base excision repair, " Oncology Reports, vol. 30, no. 4, pp. 1581-1586, 2013.
39. K.W. Caldecott, "DNAsingle-strand break repair and spinocerebellar ataxia, " Cell, vol. 112, no. 1, pp. 7-10, 2003.
40. R. M. Taylor, D. J. Moore, J. Whitehouse, P. Johnson, and K. W. Caldecott, " A cell cycle-specific requirement for the XRCC1 BRCT II domain during mammalian DNA strand break repair, " Molecular and Cellular Biology, vol. 20,no. 2, pp. 735-740, 2000.
41. A. E.Vidal, S. Boiteux, I.D.Hickson, and J. P. Radicella, " XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions, " The EMBO Journal, vol. 20, no. 22, pp. 6530-6539, 2001.
42. V. Burkart, H. Liu, K. Bellmann et al., " Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70," Journal of Biological Chemistry, vol. 275, no. 26, pp. 19521-19528, 2000.
43. F. Mendez, M. Sandigursky, W. A. Franklin, M. K. Kenny, R. Kureekattil, and R. Bases, " Heat-shock proteins associated with base excision repair enzymes inHeLa cells," Radiation Research, vol. 153, no. 2, pp. 186-195, 2000.
44. M. K. Kenny, F. Mendez, M. Sandigursky et al., " Heat shock protein 70 binds to human apurinic/apyrimidinic endonuclease and stimulates endonuclease activity at abasic sites, " Journal of Biological Chemistry, vol. 276, no. 12, pp. 9532-9536, 2001.
45. F. Mendez, M. Sandigursky, R. P. Kureekattil, M. K. Kenny, W. A. Franklin, and R. Bases, " Specific stimulation of human apurinic/apyrimidinic endonuclease by heat shock protein 70, " DNA Repair, vol. 2, no. 3, pp. 259-271, 2003.
46. M. R. Kelley and S. H. Parsons, "Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1, " Antioxidants and Redox Signaling, vol. 3, no. 4, pp. 671-683, 2001.
47. M. R. Kelley, M. M. Georgiadis, and M. L. Fishel, "APE1/Ref-1role in redox signaling: translational applications of targ eting the redox function of the DNA repair/redox protein APE1/Ref-1," CurrentMolecular Pharmacology, vol. 5, no. 1,pp. 36-53, 2012.
48. K. Hirota, M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi, " Ap-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 3633-3638, 1997.
49. L. J. Walker, C. N. Robson, E. Black, D. Gillespie, and I. D. Hickson, " Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding, " Molecular and Cellular Biology, vol. 13, no. 9, pp. 5370-5376, 1993.
50. C. D. Mol, T. Izumi, S. Mitra, and J. A. Talner, "DNA-bound structures and mutants reveal abasic DNA binding by APE1 DNA repair and coordination," Nature, vol. 403, no. 6768, pp. 451-456, 2000.
51. M. H. Luo, J. Zhang, H. Z. He et al., " Characterization of the redox activity and disulfide bond formation in apurinic/apyrimidinic endonuclease, " Biochemistry, vol. 51, no. 2, pp. 695-705, 2012.
52. S. Xanthoudakis and T. Curran, "Identification and characterization of Ref-1, a nuclear protein that fac ilitates AP-1 DNAbinding activity," The EMBO Journal, vol. 11, no. 2, pp. 653-665, 1992.
53. X. Cao, F. Kambe, S. Ohmori, and H. Seo, " Oxidoreductive modification of two cysteine residues in paired domain by Ref-1 regulates DNA-binding activity of Pax-8, " Biochemical and Biophysical Research Communications ,297 ,2,288-293,2002.
54. M. Ema, K. Hirota, J. Mimura et al., " Molecular mechanisms of transcription activation by HLF and HIF1 in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300, "TheEMBOJournal, vol. 18,no. 7, pp. 1905-1914, 1999.
55. K. Hirota, M. Murata, Y. Sachi et al., " Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-B, " Journal of Biological Chemistry, vol. 274, no. 39, pp. 27891-27897, 1999.
56. Lando D.,Pongratz I.,Poellinger L.,Whitelaw M.L. A redox mechanism controls differential DNA binding activities of hypoxia-inducible factor (HIF) 1 and the HIF-like factor, "The Journal of Biological Chemistry 2000 275 7 4618-4627.
57. G. Tell, A. Zecca, L. Pellizzari et al., " An " environment to nucleus" signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation," Nucleic Acids Research, vol. 28, no. 5, pp. 1099-1105, 2000.
58. M.Ueno,H.Masutani, R. J. Arai et al., " Thioredoxin-dependent redox regulation of p53-mediated p21 activation," Journal of Biological Chemistry, vol. 274, no. 50, pp. 35809-35815, 1999.
59. Y. Akamatsu, T. Ohno, K. Hirota, H. Kagoshima, J. Yodoi, and K. Shigesada, " Redox regulation of the DNA binding activity in transcription factor PEBP2 the roles of two conserved cysteine residues: the roles of two conserved cysteine residues, " The Journal of Biological Chemistry, vol. 272, no.23, pp. 14497-14500, 1997.
60. R. P. Huang and E. D. Adamson, "Characterization of the DNA-binding properties of the e arly growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism," DNA and Cell Biology, vol. 12, no. 3, pp. 265-273, 1993.
61. S. Xanthoudakis, G. Miao, F.Wang, Y. C. Pan, and T. Curran, " Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme," Journal of Cellular Biochemistry, vol. 11, no. 9, pp. 3323-3335, 1993.
62. C. Abate , L. Patel, F. J. Rauscher III, and T. Curran, " Redox regulation of Fos and Jun DNA-binding activity in vitro," Science, vol. 249, no. 4973, pp. 1157-1161, 1990.
63. L. Jayaraman, K. G. K. Murthy, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives, " Identification of redox/repair protein Ref-1 as a potent activator of p53," Genes and Development, vol. 11, no. 5, pp. 558-570, 1997.
64. P. Hainaut and J. Milner, "Redox modulation of p53 conformation and sequence-specific DNA binding in vitro, " Cancer Research, vol. 53, no. 18, pp. 4469-4473, 1993.
65. M.-H. Luo, H.-Z. He, M. R. Kelley, and M. M. Georgiadis, " Redox regulation of DNA repair: implications for human health and cancer therapeutic development," Antioxidants & Redox Signaling, vol. 12, no. 11, pp. 1247-1269, 2010.
66. S. Sengupta and C. C. Harris, "p53: traffic cop at the crossroads of DNA repair and recombination, " Nature Reviews Molecular Cell Biology, vol. 6, no. 1, pp. 44-55, 2005.
67. 66] H. K. Hamadeh, K. J. Trouba, R. P. Amin, C. A. Afshari, and D. Germolec, " Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes," Toxicological Sciences, vol. 69, no. 2, pp. 306-316, 2002.
68. A. S. Andrew, A. J.Warren, A. Barchowsky et al., " Genomic and proteomic profiling of responses to toxic metals in human lung cells," Environmental Health Perspectives, vol. 111, no. 6, pp. 825-838, 2003.
69. Y. Hu, X. M. Jin, and E. T. Snow, " Effect of arsenic on transcription factor AP-1 and NF-B DNA binding activity and related gene expression," Toxicology Letters, vol. 133, no. 1, pp. 33-45, 2002.
70. P. Sykora and E. T. Snow, " Modulation of DNA polymerase beta-dependent base excision repair in cultured human cells after low dose exposure to arsenite, " Toxicology and Applied Pharmacology, vol. 228, no. 3, pp. 385-394, 2008.
71. H. Fung, P. Liu, and B. Demple, "ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 co unteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis," Molecular and Cellular Biology, vol. 27, no. 24, pp. 8834-8847, 2007.
72. J. Fujihara, M. Soejima, T. Yasuda et al., " Polymorphic trial in oxidative damage of arsenic exposed Vietnamese," Toxicology and Applied Pharmacology, vol. 256, no. 2, pp. 174-178, 2011.
73. C.V. Breton,W. Zhou, M. L.Kile et al., " Susceptibility to arsenicinduced skin lesions from polymorphisms in base excision repair genes, " Carcinogenesis, vol. 28, no. 7, pp. 1520-1525, 2007.
74. D. R. McNeill, A. Narayana, H. Wong, and D. M. Wilson III, " Inhibition of Ape1 nuclease activity by lead, iron, and cadmium," Environmental Health Perspectives, vol. 112, no. 7, pp. 799-804, 2004.
75. I. Hamann, C. Kö nig, C. Richter, G. Jahnke, and A. Hartwig, " Impact of cadmium on hOGG1 and APE1 as a function of the cellular p53 status," Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, vol. 736, no. 1- 2, pp. 56-63, 2012.
76. S. A. Al Bakheet, I. M. Attafi, Z. H. Maayah, A. R. Abd-Allah, Y. A. Asiri, and H. M. Korashy, " Effect of long-term human exposure to environmental heavy metals on the expression of detoxification and DNA repair genes, " Environmental Pollution, vol. 181, pp. 226-232, 2013
77. A. Bravard,A. Campalans,M. Vacher,et al. Inactivation by oxidation and recruitment into stress granules of hOGG1 but not APE1 in human cells exposed to sub-lethal concentrations of cadmium, " Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 685, 1?2 ,61-69, 2010
78. M. Scortegagna and I.Hanbauer, " IncreasedAP-1DNA-binding activity and nuclear REF-1 accumulation in lead-exposed primary cultures of astrocytes," Neurochemical Research, vol. 25, no. 6, pp. 861-866, 2000.
79. J. Ga rciá-Lestón, J. Roma-Torres, M. Vilares et al., " Genotoxic effects of occupational exposure to lead and influence of polymorphisms in genes involved in lead toxicokinetics and in DNA repair, " Environment International, vol. 43, no. 1, pp. 29-36, 2012.
80. S. la Maestra, G. E. Kisby, R. T. Micale et al., " Cigarette smoke induces DNA damage and alters base-excision repair and tau levels in the brain of neonatal mice," Toxicological Sciences, vol. 123, no. 2, pp. 471-479, 2011.
81. Y. Lo, Y. Jou, C. Hsiao et al., " A polymorphism in the APE1 gene promoter is associated with lung cancer risk," Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 1, pp. 223-229, 2009.
82. H. Ito, K. Matsuo, N. Hamajima et al., "Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk," Carcinogenesis vol. 25, no. 8, pp. 1395-1401, 2004.
83. B. Agaçhan, O. Küçükhüseyin, P. Aksoy et al., "Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking, " Anticancer Research, vol. 29, no. 6, pp. 2417-2420, 2009.
84. K.Osawa,A.Miyaishi, K. Uchino et al., " APEX1 Asp148glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese," Asian Pacific Journal of Cancer Prevention, vol. 11, no. 5, pp. 1181-1186, 2010.
85. M. Huang, C. P. Dinney, X. Lin, J. Lin, H. B. Grossman, and X. Wu, " High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility, " Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 1, pp. 84-91, 2007.
86. R. R. Misra, D. Ratnasinghe, J. A. Tangrea et al., " Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland, " Cancer Letters, vol. 191, no. 2, pp. 171-178, 2003.
87. C. Ryk, R. Kumar, R. K. Thirumaran, and S. Hou, " Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never-and ever-smokers," Lung Cancer, vol. 54, no. 3, pp. 285-292, 2006.
88. P. D. Terry, D. M. Umbach , and J. A. Taylor, " APE1 genotype and risk of bladder cancer: evidence for effect modification by smoking," International Journal of Cancer, vol. 118, no. 12, pp. 3170-3173, 2006.
89. A. Izzotti, C. Cartiglia, M. Longobardi et al., " Alterations of gene expression in skin and lung of mice exposed to light and cigarette smoke," The FASEB Journal, vol. 18, no. 13, pp. 1559-1561, 2004.
90. W. W. Au, S. A. Salama, and C. H. Sierra-Torres, " Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays," Environmental Health Perspectives, vol. 111, no. 15, pp. 1843-1850, 2003.
91. A. Campalans, R. Amouroux, A. Bravard, B. Epe, and J. P. Radicella, " UVA irradiation induces relocalisation of the DNA repair protein hOGG1 to nuclear speckles," Journal of Cell Science, vol. 120, no. 1, pp. 23-32, 2007.
92. J. J. Hu, T. R. Smith, M. S. Miller, H. W. Mohrenweiser, A. Golden, and L. D. Case, " Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity, " Carcinogenesis, vol. 22, no. 6, pp. 917-922, 2001.
93. J. J. Hu, T. R. Smith, M. S. Miller, K. Lohman, and L. D. Case, " Genetic regulation of ionizing radiation sensitivity and breast cancer risk," Environmental and Molecular Mutagenesis, vol. 39, no. 2- 3, pp. 208-215, 2002.
94. M. G. Andreassi, I. Foffa, S. Ma nfredi, N. Botto, A. Cioppa, and E. Picano, " Genetic polymorphisms in XRCC1,OGG1, APE1 and XRCC3 DNA repair genes, ionizing radiation exposure and chromosomal DNA damage in interventional cardiologists, " Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis, vol. 666, no. 1- 2, pp. 57-63, 2009.
95. X. Gu, Y. Cun, M. Li et al., " Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by XRay irradiation in lung cancer cells, " International Journal of Medical Sciences, vol. 10, no. 7, pp. 870-882, 2013.
96. Z. Zhang, X. Yang, D. Wang et al., " Nm23-H1 protein binds to APE1 at AP sites and stimulates AP endonuclease activity following ionizing radiation of the human lung cancer A549 cells, " Cell Biochemistry and Biophysics, vol. 61, no. 3, pp. 561-572, 2011.
97. A. Gdowicz-Klosok, M.Widel, and J. Rzeszowska-Wolny, " The influence of XPD, APE1, XRCC1, and NBS1 polymorphic variants on DNA repair in cells exposed to X-rays," Mutation Research-Genetic Toxicology and Environmental Mutagenesis, vol. 755, no. 1, pp. 42-48, 2013.
98. B. R. Berquist,D. R. McNeill,D. M. Wilson III Characterization of abasic endonuclease activity of human Ape1 on alternative substrates, as well as effects of ATP and sequence context on AP site incision, " Journal of Molecular Biology ,379 ,1, 17-27, 2008.
99. P. F. Liu and B. Demple, "DNA repair in mammalian mitochondria: much more th an we thought?" Environmental and Molecular Mutagenesis, vol. 51, no. 5, pp. 417-426, 2010.
100. T. Barnes, W. Kim, A. K. Mantha et al., " Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA, " Nucleic Acids Research, vol. 37, no. 12, pp. 3946-3958, 2009.
101. J. E. J. Guikema, E. K. Linehan, D. Tsuchimoto et al., " APE1-And APE2-dependent DNA breaks in immunoglobulin class switch recombination," Journal of Experimental Medicine, vol. 204, no. 12, pp. 3017-3026, 2007.
102. S. Masani, L. Han, and K. Yu, "Apurinic/apy rimidinic endonuclease 1 is the essential nuclease during immunoglobulin class switch recombination," Molecular and Cellular Biology, vol. 33, no. 7, pp. 1468-1473, 2013.
103. L. B. Chiarini, F. G. Freitas, H. Petrs-Silva, and R. Linden, " Evidence that the bifunctional redox factor/AP endonuclease Ref-1 is an anti-apoptotic protein associated with differentiation in the developing retina, " Cell Death and Differentiation, vol. 7, no. 3, pp. 272-281, 2000.
104. R. Abbotts and S. Madhusudan, "Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer, " Cancer Treatment Reviews, vol. 36, no. 5, pp. 425-435, 2010.
105. M. L. Fishel, Y.He, A. M. Reed et al., " Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth, " DNA Repair, vol. 7, no. 2, pp. 177-186, 2008.
106. Y. L. Jiang, S. Y. Zhou, G. E. Sandusky, M. R. Kelley, and M. L. Fishel, " Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression, " Cancer Investigation, vol. 28, no. 9, pp. 885-895, 2010.
107. D. H. Moore, H. Mic hael, R. Tritt, S. H. Parsons, and M. R. Kelley, " Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers," Clinical Cancer Research, vol. 6, no. 2, pp. 602-609, 2000.
108. G. Tell,L. Pellizzari,C. Pucillo,et al. TSH controls Ref-1 nuclear translocation in thyroid cells Journal of Molecular Endocrinology ,24 , 3 ,383-390 ,2000
109. D.Wang, M. Luo, and M. R. Kelley, " Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition, " Molecular CancerTherapeutics, vol. 3, no. 6, pp. 679-686, 2004.
110. C. J. Herring, C. M. L. West, D. P. Wilks et al., "Levels of theDNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers," vol. 78, no. 9, pp. 1128-1133, 1998.
111. D.-B. Xiang, Z.-T. Chen, D. Wang et al., " Chimeric adenoviral vector Ad5/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo, " Cancer Gene Therapy, vol. 15, no. 10, pp. 625-635, 2008.
112. S. Chen, G. Xiong, S. Wu, and J. Mo, "Downregu lation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro," Cancer Biotherapy and Radiopharmaceuticals, vol. 28, no. 2, pp. 169-176, 2013.
113. K. A. Robertson, H. A. Bullock, Y. Xu et al., " Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation, " Cancer Research, vol. 61, no. 5, pp. 2220-2225, 2001.
114. T. Xi, I. M. Jones, and H. W. Mohrenweiser, " Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function, " Genomics, vol. 83, no. 6, pp. 970-979, 2004.
115. M. Z.Hadi,M.A.Coleman,K. Fidelis, H.W.Mohrenweiser, and D. M.Wilson III, " Functional characterization of Ape1 variants identified in the human population," Nucleic Acids Research, vol. 28, no. 20, pp. 3871-3879, 2000.
116. R. J. Hung, J. Hall, P. Brennan, and P. Boffetta, " Genetic polymorphisms in the base excision repair pathway and cancer risk: a huge review," The American Journal of Epidemiology, vol. 162, no. 10, pp. 925-942, 2005.
117. E. Canbay, B. Agachan, M. Gu lluoglu et al., " Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer," Anticancer Research, vol. 30, no. 4, pp. 1359-1364, 2010.
118. rffrt [117] E. Canbay, B. Cakmakoglu, U. Zeybek et al., " Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in aTurkish population," CurrentMedical Research andOpinion, vol. 27, no. 7, pp. 1295-1302, 2011.
119. L. Chen,C. B. Ambrosone,J. Lee,T. A. Sellers,J. Pow-Sang,J. Y. Park Association between polymorphisms in theDNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans Journal of Urology ,175 , 1 ,108-112 ,2006
120. C. Li,Z. Liu,L. Wang,et al. Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma," Carcinogenesis 27 9 1894-1901 2006.
121. Y. Li, S. Li, Z. Wu et al., " Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a Northeast Chinese population, " Medical Oncology, vol. 30, no. 2, article no. 505, 2013.
122. H. F. Kang, Z. J. Dai, X. B. Ma et al., " A genetic variant in the promoter of APE1 gene (?656 T > G) is associated with breast cancer risk and progression in a Chinese population, " Gene, vol. 531, no. 1, pp. 97-100, 2013.
123. M.Wang, H. Chu, S.Wang et al., " Genetic variant in APE1 gene promoter contributes to cervical cancer risk," American Journal of Obstetrics and Gynecology, vol. 209, no. 4, pp. 360.e1-360.e7, 2013.
124. M. L.Wang, C.Qin, J. A. Zhu et al., " Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer," DNA and Cell Biology, vol. 29, no. 6, pp. 303-311, 2010.
125. J. Lu, S. Y. Zhang, D. Chen et al., " Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility, " The FASEB Journal, vol. 23, no. 10, pp. 3459-3469, 2009.
126. Z. Li,W. Guan, M . Li et al., " Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population," Archives of Medical Research, vol. 42, no. 3, pp. 226-234, 2011.
127. Y. Ji, P. Zhan, J.Wang, L. Qiu, and L. Yu, " APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis," Molecular Biology Reports, vol. 38, no. 7, pp. 4537-4543, 2011.
128. Q. Deng, L. Sheng, D. Su et al., " Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China," Medical Oncology, vol. 28, no. 3, pp. 667-672, 2011.
129. D. M. Wilson III and D. R. McNeill, "Base excision repair and the central nervous system, " Neuroscience, vol. 145, no. 4, pp . 1187-1200, 2007.
130. M. R. Vasko, C. Guo, and M. R. Kelley, " The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress," DNA Repair, vol. 4, no. 3, pp. 367-379, 2005.
131. Z. Tan, N. Sun, and S. S. Schreiber, "Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimer's hippocampus, " NeuroReport, vol. 9, no. 12, pp. 2749-2752, 1998.
132. G.Marcon, G. Tell, L. Perrone et al., " APE1/Ref-1 in Alzheimer's disease: An immunohistochemical study," Neuroscience Letters, vol. 466, no. 3, pp. 124-127, 2009.
133. G. E. Kisby J. Milne and C. Sweatt Evidence of reduced DNA repair in amyotrophic lateral sclerosis brain tissue NeuroReport ,8 , 6, 1337-1340 , 1997
134. M. Gencer, S. Dasdemir, B. Cakmakoglu et al., " DNA repair genes in Parkinson's disease," Genetic Testing and Molecular Biomarkers, vol. 16, no. 6, pp. 504-507, 2012.
135. Z. L. Olkowski, " Mutant AP endonuclease in patients with amyotrophic lateral sclerosis," NeuroReport, vol. 9, no. 2, pp. 239-242, 1998.
136. V. A. Bohr, "Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells," Free Radical Biology and Medicine, vol. 32, no. 9, pp. 804-812, 2002.
137. G.W. Intano, E. J. Cho, C. A. McMahan, andC.A.Walter, " Agerelated base excision repair activity in mouse brain and liver nuclear extracts," Journals of Gerontology A, vol. 58, no. 3, pp. 205-211, 2003.
138. U. Swain and K. S. Rao, "Study of DNA damage via the comet assay and base excision repair activities in rat brain neurons and astrocytes during aging," Mechanisms of Ageing and Development, vol. 132, no. 8- 9, pp. 374-381, 2011.
139. P. Angkeow, S. S. Deshpande, B. Qi et al., " Redox factor-1: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis," Cell Death and Differentiation, vol. 9, no. 7, pp. 717-725, 2002.
140. Y. Zhang, L. Zhang, L. Zhang, J. Bai, H. Y. Ge, and P. Liu, " Expression changes in DNA repair enzymes and mitochondrial DNA damage in aging rat lens," Molecular Vision, vol. 16, pp. 1754-1763, 2010
141. B. Szczesny S. Mitra Effect of aging on intracellular distribution of abasic (AP) endonuclease 1 in the mouse liver Mechanisms of Ageing and Development, 126 ,10 1071- 1078, 2005
142. S. Madlener, T. Strobel, S. Vose et al., " Essential role for mammalian apurinic/apyrimidinic (AP) endonuclease Ape1/Ref-1 in telomere maintenance, " Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 44, pp. 17844-17849, 2013.
143. A. Tekeli, S. Isbir, A. Ergen et al., " APE1 and XRCC3 polymorphisms and myocardial infarction," In Vivo, vol. 22, no. 4, pp. 477-480, 2008.
144. A. Bardia, S. K. Tiwari, S. Gunisetty et al., " Functional polymorphisms in XRCC-1 and APE-1 contribute to increased apoptosis and risk of ulcerative colitis, " Inflammation Research, vol. 61, no. 4, pp. 359-365, 2012.
145. A. Jiang, H. Gao, M. R. Kelley, and X. Qiao, "Inhibition of APE 1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo," Vision Research, vol. 51, no. 1, pp. 93-100, 2011.
146. P. Carmeliet, Y. Dor, J. M. Herbert et al., " Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, " Nature, vol. 394, no. 6692, pp. 485-490, 1998.
147. R. F. Gariano and T. W. Gardner, "Retinal angiogenesis in development and disease, " Nature, vol. 438, no. 7070, pp. 960-966, 2005.
148. A. d'Errico, N. Malats, P. Vineis, and P. Boffetta, " Review of studies of selected metabolic polymorphisms and cancer.," IARC scientific publications, no. 148, pp. 323-393, 1999.
149. IARCWorking Group on the Evaluation of Carcinogenic Risks to Humans, " Some drinking-water disinfectants and contaminants, including arsenic," IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 84, pp. 1-477, 2004.
150. A. D. Kligerman and A. H. Tennant, "Insights into the carcinogenic mode of action of arsenic, " Toxicology a nd Applied Pharmacology, vol. 222, no. 3, pp. 281-288, 2007.
151. A. Szymá nska-Chabowska, J. Antonowicz-Juchniewicz, and R. Andrzejak, " The concentration of selected cancer markers (TPA, TPS, CYFRA 21-1, CEA) in workers occupationally exposed to arsenic (As) and some heavy metals (Pb, Cd) during a two-year observation study, " International Journal of Occupational Medicine and Environmental Health, vol. 20, no. 3, pp. 229-239, 2007.
152. A. Diá z-Villaseñor, A. L. Burns, M. Hiriart, M. E. Cebrián, and P.Ostrosky-Wegman, " Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus," Toxicology and Applied Pharmacology, vol. 225, no. 2, pp. 123-133, 2007.
153. E. M. Schmuck, P. G. Board, A. K.Whitbread et al., " Characterization of themonomethylarsonate reductase and d ehydroascorbate reductase activities of Omega class glutathione transferase variants: Implications for arsenic metabolism and the age-atonset of Alzheimer's and Parkinson's diseases, " Pharmacogenetics and Genomics, vol. 15, no. 7, pp. 493-501, 2005.
154. A. Vahidnia, G. B. van der Voet, and F. A. de Wolff, "Arsenic neurotoxicity-a review, " Human and Experimental Toxicology, vol. 26, no. 10, pp. 823-832, 2007.
155. C. Huang, Q. D. Ke, M. Costa, and X. Shi, "Molecular mechanisms of arsenic carcinogenesis, " Molecular and Cellular Biochemistry, vol. 255, no. 1 -2, pp. 57-66, 2004.
156. ] E. T. Snow, P. Sykora, T. R. Durham, and C. B. Klein, " Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?" Toxicology and Applied Pharmacology, vol. 207, supplememet 1, no. 2, pp. 557-564, 2005.
157. J. Lunec, K. A. Holloway, M. S. Cooke, S. Faux, H. R. Griffiths, and M. D. Evans, " Urinary 8-oxo-2-deoxyguanosine: redox regulation of DNA repair in vivo?" Free Radical Biology and Medicine, vol. 33, no. 7, pp. 875-885, 2002.
158. P. Vodicka, R. Stetina, V. Polakova et al., " Association of DNA repair polymorphisms withDNA repair functional outcomes in healthy human subjects, " Carcinogenesis, vol. 28, no. 3, pp. 657-664, 2007.
159. " Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions, Lyon, 9-16 February 1993, " IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 58, pp. 1-415, 1993.
160. M. P.Waalkes, "Cadmiumcarcinogenesis, "Mutation Research- Fundam ental and Molecular Mechanisms of Mutagenesis, vol. 533, no. 1- 2, pp. 107-120, 2003.
161. M.Waisberg,P. Joseph, B.Hale, andD. Beyersmann, " Molecular and cellular mechanisms of cadmium carcinogenesis," Toxicology, vol. 192, no. 2- 3, pp. 95-117, 2003.
162. G. Bertin D. AverbeckCadmium: Cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review) Biochimie ,88 , 11, 1549-1559 ,2006.
163. P. Joseph, "Mechanisms of cadmiumcarcinogenesis, " Toxicology and Applied Pharmacology, vol. 238, no. 3, pp. 272-279, 2009.
164. M. L. Hegde, T. K. Hazra, and S. Mitra, "Early steps in the DNA base excision/single-strand interruption repair pa thway in mammalian cells," Cell Research, vol. 18,no. 1, pp. 27-47, 2008.
165. C. Giaginis, E. Gatzidou, and S. Theocharis, "DNA repair systems as targets of cadmium toxicity, " Toxicology and Applied Pharmacology, vol. 213, no. 3, pp. 282-290, 2006.
166. "Lead and lead compounds: lead and inorganic lead compounds, " IARC Monographs Evaluation Carcinogenic Risks to Humans, vol. 23, supplement 7, pp. 1-729, 1987.
167. "Inorganic and organic lead compounds, " IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 87, pp. 1-471, 2006.
168. L. Järup, "Hazards of heavy metal contamination, " British Medical Bulletin, vol. 68, pp. 167-182, 2003.
169. J. Patocka and K. Cerńy, "Inorganic lead toxicology, " Acta Medica, vol. 46, no. 2, pp. 65-72, 2003.
170. J. Mé ndez-Gómez, G. Garciá-Vargas, L. López-Carrillo et al., " Genotoxic effects of environmental exposure to arsenic and lead on children in Region Lagunera, Mexico, " Annals of the New York Academy of Sciences, vol. 1140, pp. 358-367, 2008.
171. J.Garcia-Leston, J.Mendez, E. Pasaro, and B. Laffon, " Genotoxic effects of lead: an updated review," Environment International, vol. 36, no. 6, pp. 623-636, 2010.
172. D. R. McNeill, H. Wong, A. Narayana, and D. M. Wilson III, " Lead promotes abasic site accumulation and co-mutagenesis in mammalian cells by inhibiting themajor abasic endonuclease Ape1, " Molecular Carcinogenesis, vol. 46, no. 2, pp. 91-99, 2007.
173. S. Grö sch, G. Fritz, and B. Kaina, "Apurinic endonuclease (Ref-1) is induced in mammalian cells by oxidative stress and involved in clastogenic adaptation," Cancer Research, vol. 58,no. 19, pp. 4410-4416, 1998.
174. C. V. Ramana, I. Boldogh, T. Izumi, and S.Mitra, " Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals, " Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 9, pp. 5061-5066, 1998.
175. P. Boyle, "Cancer, cigarette smoking and premature death in Europ e: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996," Lung Cancer, vol. 17, no. 1, pp. 1-60, 1997.
176. S. S. Hecht, "Cigarette smoking and lu ng cancer: chemical mechanisms and approaches to prevention," The Lancet Oncology, vol. 3, no. 8, pp. 461-469, 2002.
177. Q. Wei and M. R. Spitz, "The role of DNA repair capacity in susceptibility to lung cancer: a review," Cancer and Metastasis Reviews, vol. 16, no. 3- 4, pp. 295-307, 1997.
178. M. R. Spitz, X. Wu, Y. Wang et al., " Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients, " Cancer Research, vol. 61, no. 4, pp. 1354-1357, 2001.
179. Q. Wei, L. Cheng, W. K. Hong, andM. R. Spitz, " ReducedDNA repair capacity in lung cancer patients," Cancer Research, vol. 56, no. 18, pp. 4103-4107, 1996.
180. H. Shen, M. R. Spitz, Y. Qiao et al., " Smoking, DNA repair capacity and risk of nonsmall cell lung cancer," International Journal of Cancer, vol. 107, no. 1, pp. 84-88, 2003.
181. C. N. Kundu, R. Balusu, A. S. Jaiswal, C. G. Gairola, and S. Narayan, " Cigarette smoke condensate-induced level of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells, " Oncogene, vol. 26, no. 10, pp. 1428-1438, 2007.
182. P. Mohapatra, S. R. Satapathy, D. Das et al., " Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of longpatchbase excision repair pathway, " Toxicology and Applied Pharma cology, vol. 275, no. 3, pp. 221-231, 2014.
183. A. S. Jaiswal, H. Panda, C. A. Pampo et al., " Adenomatous polyposis coli-mediated accumulation of abasic dna lesions lead to cigarette smoke condensate-induced neoplastic transformation of normal breast epithelial cells, " Neoplasia, vol. 15, no. 4, pp. 454-460, 2013.
184. E. Ron Ionizing radiation and cancer risk: evidence from epidemiology Radiation Research 150 5 S30-S41 1998.
185. D. J. Brenner, R. Doll, D. T. Goodhead et al., " Cancer risks attributable to low doses of ionizing radiation: assessing what we really know, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 13761-13766, 2003.
186. E. J. Hall and D. J. Brenner, "Cancer risks from diagnostic radiology, " British Journal of Radiology, vol. 81, no. 965, pp. 362-378, 2008.
187. D. J. Brenner, "Should we be concerned about the rapid increase in CT usage? " Reviews on Environmental Health, vol. 25, no. 1, pp. 63-67, 2010.
188. M. de Santis,E.Cesari, E.Nobili,G.Straface, A. F. Cavaliere, and A. Caruso, " Radiation effects on development," Birth Defects Research C: Embryo Today: Reviews, vol. 81, no. 3, pp. 177-182, 2007.